News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Interim Report January-March 2014 Chrontech Pharma AB


5/9/2014 9:04:16 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

· Research and development costs amounted to SEK 0.4 (0.0) m
· Loss after tax was SEK -1.4 (-1.5) m
· Earnings per share were SEK -0.01 (-0.01)
· The company had no net sales for the period
· ChronTechs therapeutic hepatitis D vaccine activates an immune response that can enter the liver and eliminate liver cells that produce parts of HDV

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES